The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prevalence and outcome of mutations (mut) in the Fanconi anemia (FA) DNA repair pathway among head and neck cancer (H&N Ca) patients (pts).
Nooshin Hashemi Sadraei
Honoraria - Genentech
Kakajan Komurov
No relevant relationships to disclose
Ann Marie Egloff
No relevant relationships to disclose
Lindsey Romick-Rosendale
No relevant relationships to disclose
Jung Ying
No relevant relationships to disclose
Susanne Wells
No relevant relationships to disclose
Jennifer Grandis
Research Funding - Bristol-Myers Squibb; Novartis